|
|
Brisken, C., and Duss, S. (2007). Stem cells and the stem cell niche in the breast: an integrated hormonal and developmental perspective. Stem Cell Rev 3, 147-156. Abstract
Ciarloni, L., Mallepell, S., and Brisken, C. (2007). Amphiregulin is an essential mediator of estrogen receptor {alpha} function in mammary gland development. Proc Natl Acad Sci U S A 104, 5455-5460. Abstract
Duss, S., Andre, S., Nicoulaz, A. L., Fiche, M., Bonnefoi, H., Brisken, C., and Iggo, R. D. (2007). An estrogen-dependent model of breast cancer created by transformation of normal human mammary epithelial cells. Breast Cancer Res 9, R38. Abstract
 |
Ayyanan, A., Civenni, G., Ciarloni, L., Morel, C., Mueller, N., Lefort, K., Mandinova, A., Raffoul, W., Fiche, M., Dotto, G. P., and Brisken, C. (2006). Increased Wnt signaling triggers oncogenic conversion of human breast epithelial cells by a Notch-dependent mechanism. Proc Natl Acad Sci U S A 103, 3799-3804 - Winner of the January 2007 Santa Cruz Investigator Award. Abstract
Brisken, C., and Rajaram, R. D. (2006). Alveolar and lactogenic differentiation. J Mammary Gland Biol Neoplasia 11, 239-248. Abstract
Mallepell, S., Krust, A., Chambon, P., and Brisken, C. (2006). Paracrine signaling through the epithelial estrogen receptor alpha is required for proliferation and morphogenesis in the mammary gland. Proc Natl Acad Sci U S A 103, 2196-2201. Abstract
|
Devgan, V., Mammucari, C., Millar, S. E., Brisken, C. , and Dotto, G. P. (2005). p21WAF1/Cip1 is a negative transcriptional regulator of Wnt4 expression downstream of Notch1 activation. Genes Dev 19, 1485-1495. Abstract
Farmer, P., Bonnefoi, H., Becette, V., Tubiana-Hulin, M., Fumoleau, P., Larsimont, D., Macgrogan, G., Bergh, J., Cameron, D., Goldstein, D., Duss, S., Nicoulaz, A. L., Brisken, C., Fiche, M., Delorenzi, M. , and Iggo, R. (2005). Identification of molecular apocrine breast tumours by microarray analysis. Oncogene 24, 4660-4671. Abstract
|
Chu, EY, Hens, J, Andl, T, Kairo, A, Yamaguchi, TP, Brisken, C, Glick, A, Wysolmerski, JJ, and Millar, SE (2004). Canonical WNT signaling promotes mammary placode development and is essential for initiation of mammary gland morphogenesis. Development 131, 4819-4829. Abstract
|
Gass, S, Harris, J, Ormandy, C, and Brisken, C. (2003). Using gene expression arrays to elucidate transcriptional profiles underlying prolactin function. J Mammary Gland Biol Neoplasia. 8, 269-285 Abstract
|
Brisken, C., Ayyannan, A., Doppler,W. (2002). Prolactin signaling and Stat5: going their own separate ways? Breast Cancer Res. 4, 209-212. Abstract
Brisken, C., Ayyannan, A., Nguyen, C., Heineman, A., Reinhardt, F., Tan, J., Dey, S.K., Dotto, G. P., Weinberg, R.A. (2002). IGF-2 is a mediator of prolactin-induced proliferation/morphogenesis in the breast. Dev Cell. 3, 877-887. Abstract
Brisken, C. (2002). Hormonal control of alveolar development and its implications for breast carcinogenesis. J. Mammary Gland Biol Neoplasia. 7, 39-48. Abstract
Brisken, C., Socolovsky, M., Lodish, H. F., and Weinberg, R. (2002). The signaling domain of the erythropoietin receptor rescues prolactin receptor-mutant mammary epithelium. Proc Natl Acad Sci U S A. 99, 14241-14245. Abstract
|
|
